Gene Biotherapeutics, Inc. Retained Earnings
Gene Biotherapeutics, Inc. had Retained Earnings of -$119.43 million as of 2020-12-31, per its 10-K/A filed 2022-04-14.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2022-04-14
- 2020-12-31: Retained Earnings (Accumulated Deficit) -$119.43M.
- 2020-09-30: Retained Earnings (Accumulated Deficit) -$118.99M.
- 2020-06-30: Retained Earnings (Accumulated Deficit) -$118.63M.
- 2020-03-31: Retained Earnings (Accumulated Deficit) -$119.06M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2020-12-31 | -$119.43M 10-K/A · filed 2022-04-14 | |
| 2020-09-30 | -$118.99M 10-Q · filed 2021-10-27 | |
| 2020-06-30 | -$118.63M 10-Q · filed 2021-09-17 | |
| 2020-03-31 | -$119.06M 10-Q · filed 2021-09-03 | |
| 2019-12-31 | -$118.91M 10-K/A · filed 2022-04-14 | |
| 2018-12-31 | -$119.78M 10-K · filed 2021-04-23 | |
| 2017-12-31 | -$119.34M 10-K · filed 2021-04-23 | |
| 2017-03-31 | -$118.03M 10-Q · filed 2017-07-28 | |
| 2016-12-31 | -$117.45M 10-K · filed 2017-07-28 | |
| 2016-09-30 | -$116.59M 10-Q · filed 2017-03-21 | |
| 2016-06-30 | -$116.20M 10-Q · filed 2017-03-06 | |
| 2016-03-31 | -$115.59M 10-Q · filed 2017-03-01 | |
| 2015-12-31 | -$114.53M 10-K · filed 2017-07-28 | -$115.16M 10-K · filed 2016-12-29 |
| 2015-09-30 | -$114.70M 10-Q · filed 2016-10-27 | |
| 2015-06-30 | -$112.88M 10-Q · filed 2016-08-29 | |
| 2015-03-31 | -$111.44M 10-Q · filed 2015-06-18 | |
| 2014-12-31 | -$110.83M 10-K · filed 2016-12-29 | |
| 2014-09-30 | -$109.19M 10-Q · filed 2014-11-19 | |
| 2014-06-30 | -$107.75M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | -$106.77M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | -$105.33M 10-K · filed 2015-05-22 | |
| 2013-09-30 | -$102.56M 10-Q · filed 2013-11-19 | |
| 2013-06-30 | -$100.79M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | -$98.68M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | -$96.41M 10-K · filed 2014-04-15 | |
| 2012-09-30 | -$94.46M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | -$92.56M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | -$90.69M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | -$88.09M 10-K · filed 2013-04-05 | |
| 2011-09-30 | -$86.01M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | -$84.41M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | -$80.96M 10-K · filed 2012-03-30 |